Cargando…
A Pilot Study of Q-switched 1064-nm Nd:YAG Laser Treatment in the Keratosis Pilaris
BACKGROUND: Keratosis pilaris (KP) is a keratinization disorder that is characterized by follicular hyperkeratosis, with surrounding erythema. Topical treatments are widely used, but their effects are limited. OBJECTIVE: To evaluate the effectiveness of the Q-switched 1064-nm Nd:YAG laser for the tr...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Dermatological Association; The Korean Society for Investigative Dermatology
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162257/ https://www.ncbi.nlm.nih.gov/pubmed/21909198 http://dx.doi.org/10.5021/ad.2011.23.3.293 |
_version_ | 1782210799566061568 |
---|---|
author | Park, Juhee Kim, Beom Joon Kim, Myeung Nam Lee, Chang Kyun |
author_facet | Park, Juhee Kim, Beom Joon Kim, Myeung Nam Lee, Chang Kyun |
author_sort | Park, Juhee |
collection | PubMed |
description | BACKGROUND: Keratosis pilaris (KP) is a keratinization disorder that is characterized by follicular hyperkeratosis, with surrounding erythema. Topical treatments are widely used, but their effects are limited. OBJECTIVE: To evaluate the effectiveness of the Q-switched 1064-nm Nd:YAG laser for the treatment of KP. METHODS: Total of 12 patients with KP were treated with a Q-switched 1064-nm Nd:YAG laser. Ten sessions of laser treatment were delivered once every two weeks. The entire lesions were treated with the following laser settings: 4.0~5.0 J/cm(2), 4-mm spot size, and three passes. Two dermatologists' clinical evaluations and patients' satisfaction were assessed between before treatment (baseline) and at 1 month after the last treatment. RESULTS: Eleven of the twelve patients showed more than grade 2 (>25%) improvement in texture and dyspigmentation in KP lesions, respectively. A half of the patients (50%) showed more than 50% improvement in the skin texture. Regarding dyspigmentation, five patients (41.7%) showed more than 50% improvement. Eleven out of twelve participants were satisfied (>25% of the Patients' self assessment) with the procedure. No significant adverse effect was observed. CONCLUSION: Although the Q-switched 1064-nm laser treatment may not be the first line therapy for KP, it might be a new treatment option for the patients with recalcitrant KP. |
format | Online Article Text |
id | pubmed-3162257 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Korean Dermatological Association; The Korean Society for Investigative Dermatology |
record_format | MEDLINE/PubMed |
spelling | pubmed-31622572011-09-09 A Pilot Study of Q-switched 1064-nm Nd:YAG Laser Treatment in the Keratosis Pilaris Park, Juhee Kim, Beom Joon Kim, Myeung Nam Lee, Chang Kyun Ann Dermatol Original Article BACKGROUND: Keratosis pilaris (KP) is a keratinization disorder that is characterized by follicular hyperkeratosis, with surrounding erythema. Topical treatments are widely used, but their effects are limited. OBJECTIVE: To evaluate the effectiveness of the Q-switched 1064-nm Nd:YAG laser for the treatment of KP. METHODS: Total of 12 patients with KP were treated with a Q-switched 1064-nm Nd:YAG laser. Ten sessions of laser treatment were delivered once every two weeks. The entire lesions were treated with the following laser settings: 4.0~5.0 J/cm(2), 4-mm spot size, and three passes. Two dermatologists' clinical evaluations and patients' satisfaction were assessed between before treatment (baseline) and at 1 month after the last treatment. RESULTS: Eleven of the twelve patients showed more than grade 2 (>25%) improvement in texture and dyspigmentation in KP lesions, respectively. A half of the patients (50%) showed more than 50% improvement in the skin texture. Regarding dyspigmentation, five patients (41.7%) showed more than 50% improvement. Eleven out of twelve participants were satisfied (>25% of the Patients' self assessment) with the procedure. No significant adverse effect was observed. CONCLUSION: Although the Q-switched 1064-nm laser treatment may not be the first line therapy for KP, it might be a new treatment option for the patients with recalcitrant KP. Korean Dermatological Association; The Korean Society for Investigative Dermatology 2011-08 2011-08-06 /pmc/articles/PMC3162257/ /pubmed/21909198 http://dx.doi.org/10.5021/ad.2011.23.3.293 Text en Copyright © 2011 Korean Dermatological Association; The Korean Society for Investigative Dermatology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Park, Juhee Kim, Beom Joon Kim, Myeung Nam Lee, Chang Kyun A Pilot Study of Q-switched 1064-nm Nd:YAG Laser Treatment in the Keratosis Pilaris |
title | A Pilot Study of Q-switched 1064-nm Nd:YAG Laser Treatment in the Keratosis Pilaris |
title_full | A Pilot Study of Q-switched 1064-nm Nd:YAG Laser Treatment in the Keratosis Pilaris |
title_fullStr | A Pilot Study of Q-switched 1064-nm Nd:YAG Laser Treatment in the Keratosis Pilaris |
title_full_unstemmed | A Pilot Study of Q-switched 1064-nm Nd:YAG Laser Treatment in the Keratosis Pilaris |
title_short | A Pilot Study of Q-switched 1064-nm Nd:YAG Laser Treatment in the Keratosis Pilaris |
title_sort | pilot study of q-switched 1064-nm nd:yag laser treatment in the keratosis pilaris |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162257/ https://www.ncbi.nlm.nih.gov/pubmed/21909198 http://dx.doi.org/10.5021/ad.2011.23.3.293 |
work_keys_str_mv | AT parkjuhee apilotstudyofqswitched1064nmndyaglasertreatmentinthekeratosispilaris AT kimbeomjoon apilotstudyofqswitched1064nmndyaglasertreatmentinthekeratosispilaris AT kimmyeungnam apilotstudyofqswitched1064nmndyaglasertreatmentinthekeratosispilaris AT leechangkyun apilotstudyofqswitched1064nmndyaglasertreatmentinthekeratosispilaris AT parkjuhee pilotstudyofqswitched1064nmndyaglasertreatmentinthekeratosispilaris AT kimbeomjoon pilotstudyofqswitched1064nmndyaglasertreatmentinthekeratosispilaris AT kimmyeungnam pilotstudyofqswitched1064nmndyaglasertreatmentinthekeratosispilaris AT leechangkyun pilotstudyofqswitched1064nmndyaglasertreatmentinthekeratosispilaris |